Rationale for Low-Dose Combination Therapy in Cardiovascular Risk Management
Data from recent studies have reconfirmed the importance of aggressive blood pressure (BP) control in protecting hypertensive patients from target organ damage. However, surveys performed to assess the adequacy of hypertension control in the United States have demonstrated that only one quarter of hypertensive patients are controlled at a level of 140/90 mmHg. If the currently recommended goals of 130/85 mmHg are applied, the controlled number is much less. Thus, our current approaches to the management of hypertension are failing in the most fundamental goals of treating hypertension. It is therefore crucial that we reassess the currently recommended approaches to hypertension to determine what changes need to be made in order to improve control rates.
KeywordsHypertensive Patient Side Effect Profile Losartan Potassium Amlodipine Besylate Diabetic Hypertensive Patient
Unable to display preview. Download preview PDF.
- 5.National High Blood Pressure Education Program Working Group (1983) Arch Intern Med 153: 186–193.Google Scholar
- 7.Taylor Nelson Healthcare, Epson Survey (1992) England: Copyright Cardiomonitor.Google Scholar
- 11.The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (1997) Arch Intern Med 157: 2413–2446.Google Scholar
- 12.Neutel JM, Rolf CN, Valentine SN, et al. (1996) Low dose combination therapy as first line treatment of mild-to-moderate hypertension: the efficacy and safety of bisoprolol/HCTZ versus amlodipine, enalapril and placebo. Cardiovasc Rev Rep 71: 1.Google Scholar